FAFazil Tuncay Aki

Fazil Tuncay Aki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fazil Tuncay Aki has a total of 403 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Context‐dependent effects of whole‐body vibration on reproductive function and penile tissue integrity in sedentary male rats

    by Mujdat Ayva, Senay Akin, Irem Gungor Orhan, Neslihan Coskun Akcay, Berkay Ozerklig, Kemal Kosemehmetoglu, Mesut Altan, Haydar A. Demirel, Fazil Tuncay Aki

    Sedentary behaviour is increasingly recognized as a risk factor for systemic disorders; however, its effects on male reproductive health and penile tissue integrity remain insufficiently understood. Furthermore, the therapeutic role of whole‐body vibration (WBV) has not been investigated. This study evaluated the effects of sedentary behaviour on testicular and penile tissues and examined whether WBV could attenuate these alterations. We hypothesized that sedentary behaviour would impair spermatogenesis and penile tissue integrity, whereas WBV would attenuate these effects. Thirty‐two male Wistar rats were randomized into four groups ( n = 8/group): Control, Sedentary, Sedentary+WBV and WBV. Sedentary conditions were induced for 28 days via a reduced‐cage model, with daily WBV application (45 Hz, 3 mm). Serum testosterone, sperm parameters, testicular histology and penile smooth muscle‐to‐collagen ratio were assessed. Sedentary behaviour impaired spermatogenesis, with lower Johnsen scores ( P = 0.008), reduced sperm concentration ( P = 0.006) and motility ( P  < 0.001), and increased morphological abnormalities ( P  < 0.001). It also reduced the penile smooth muscle‐to‐collagen ratio ( P  < 0.001), indicating adverse structural remodelling in erectile tissue. In sedentary animals, WBV attenuated several alterations, preserving sperm quality and cavernosal smooth muscle content. However, WBV alone impaired spermatogenesis and increased sperm morphological abnormalities in non‐sedentary animals. Serum testosterone levels did not differ significantly. In conclusion, prolonged sedentary behaviour impaired male reproductive indices and induced adverse structural remodelling of penile tissue in male rats. WBV showed context‐dependent effects, attenuating alterations under sedentary conditions while showing adverse associations in non‐sedentary animals. These findings warrant further translational investigation into the context‐dependent effects of WBV on male reproductive and penile tissues.

  • Short Bowel Syndrome Is Not a Contraindication for Kidney Transplantation

    by Tugba Tastemel Ozturk, Bora Gulhan, Ersin Gumus, Hayriye Hizarcioglu‐Gulsen, Eda Didem Kurt‐Sukur, Ali Cansu Bozaci, Fazil Tuncay Aki, Ali Duzova, Rezan Topaloglu, Fatih Ozaltin

    Background: Short bowel syndrome (SBS) is a malabsorptive condition that develops as a result of massive resection of the small intestine and causes morbidities such as chronic diarrhea, dehydration attacks, parenteral nutrition (PN) dependence, and recurrent infections. Kidney transplantation in this patient group may be complicated by aforementioned morbidities, as well as the absorption problems of immunosuppressive drugs.Methods: We report the first pediatric patient (18‐month‐old male) with SBS secondary to volvulus who underwent a successful living related kidney transplantation with a primary diagnosis of autosomal recessive polycystic kidney disease and had a successful 4‐year follow‐up without intestinal transplantation.Results: Tacrolimus, mycophenolate mofetil (MMF), and prednisolone were administered for maintenance of immunosuppression after transplantation. The patient reached therapeutic trough levels of tacrolimus with usual doses. The 4‐year renal survival was excellent without a clinical evidence of rejection, despite long‐term necessity of PN and intravenous fluids.Conclusions: Kidney transplantation should not be avoided in patients with SBS solely because of concerns about the effectiveness of immunosuppressive therapy. Prednisolone, tacrolimus, and MMF combination was effective in our case, and these drugs can be considered as first‐line agents in these patients.

  • In vitro effects of β3‐adrenoceptor agonist mirabegron on the human ureter

    by Meylis Artykov, Esin Ozcelebi, Mehmet Yildirim Sara, Ahmet Gudeloglu, Alper Bektas Iskit, Fazil Tuncay Aki

    Introduction: This study aimed to investigate the effect of mirabegron, a β3‐adrenoceptor agonist with widespread clinical use for treating overactive bladder disease, on isolated healthy human ureter strips.Materials and Methods: This was a prospective study employing a series of in vitro organ bath experiments using ureteral tissues of kidney grafts from 10 healthy donors. The ureteral strips were subjected to cumulative mirabegron concentrations (10−9–10−4.5 M). Effects on frequency or amplitude of spontaneous, 10 mM KCl‐ or EFS‐induced contractions were evaluated.Results: Mirabegron decreased the frequency of spontaneous ureteric contraction in a concentration‐dependent manner. Statistically significant decrease in the frequency of spontaneous contraction was observed at 10−8–10−4.5 M. In 10 mM KCl medium, statistically significant change in frequency was observed at 10−9–10−4.5 M. Statistically significant decrease in the amplitudes of spontaneous contraction was observed at 10−7–10−4.5 M. In a 10 mM KCl medium, statistically significant change in amplitudes was observed at 10−8–10−4.5 M.Conclusions: Mirabegron reduced the amplitude and frequency of human ureter activity in in vitro organ bath studies. This effect was achieved in a dose‐dependent manner on isolated tissue strips. Although monotherapy with mirabegron remains uncertain, this study has the potential to elucidate the mechanism underlying the effectiveness of mirabegron, particularly in combination therapy for ureteral stones.


  • Open Access

    Laparoscopy-assisted peritoneal dialysis catheter placement using a modified minimally invasive approach: A retrospective observational study

    by Necmi Bayraktar, Fazil Tuncay Aki

    Peritoneal dialysis is a reliable and effective treatment for end-stage kidney disease. However, inadequate catheter insertion can lead to mechanical dysfunction, which remains an unresolved problem. In this study, we present the initial results of a modified laparoscopic approach. This study included 38 patients who underwent peritoneal dialysis using a modified laparoscopic approach. During the procedure, a single laparoscopic trocar was employed, and peritoneal entry was performed using a percutaneous pull-apart sheath/dilator. To minimize the risk of complications, the free catheter portion was kept short in the peritoneum. The modified method was guided by proven recommendations of the standard laparoscopic technique. The mean operation time was recorded as 24.28 ± 15.5. The mean hospitalization was found to be 1.20 ± 0.72 days. The postoperative morbidity was 26.3%. The mechanical dysfunction rate was 5.26%. The median follow-up time was 20.4 ± 17.14 months. The median peritoneal dialysis catheter-free survival was 25.96 ± 4.02 months. The catheter-free survival rate was 92.11%. The modified laparoscopic approach has been demonstrated to be a safe and effective option, and initial studies have indicated that it offers several benefits over traditional methods, including a straightforward procedure with a brief duration, minimal complications, and brief hospital stay.


  • Risk Factors for Complications in Simple Nephrectomy: 17-Year Results from Single Institution

    by Meylis Artykov, Hakan Bahadır Haberal, Ömer Faruk Bahadır, Ahmet Güdeloğlu, Bülent Akdoğan, Fazıl Tuncay Aki, Cenk Yücel Bilen, Sertaç Yazıcı


  • Open Access

    Endovascular management of renal angiomyolipomas: Do coils have a benefit in terms of clinical success rates?

    by Javid Ahmadov, Ferdi Cay, Gonca Eldem, Bulent Akdogan, Cenk Yucel Bilen, Fazil Tuncay Aki, Barbaros Cil, Ali Ergen, Bora Peynircioglu

    This study evaluated single-center results of endovascular treatment in renal angiomyolipoma (AML) to determine whether there is clinical relevance of adding proximal coil embolization to distal particle embolization in terms of safety, efficacy, and retreatment rates. A retrospective analysis was performed to evaluate patients undergoing transarterial embolization for renal AMLs from January 2007 to October 2020. Parameters regarding patient and tumor characteristics, embolization technique, treatment outcome, and complications were recorded. Patients were divided into 2 groups as A (only particle group) and B (particle + coil group) based on the type of embolic agent used for treatment. Comparative analysis was performed between the 2 groups in terms of tumor size reduction, retreatment, and complication rates. In this study, 42 patients (37 (88.1%) females and 5 (11.9%) males) harboring 48 AMLs were included. The mean age was 43.46 (range, 20-78). The technical success rate was 95.8% (46 of 48 procedures). The mean size reduction was 1.94 ± 1 cm (P < .001) after treatments; however, no significant difference was seen between groups in terms of tumor size reduction. Retreatment rates were 3.1% (1 of 32 cases) in group A and 14.3% (2 of 14 cases) in group B (P = .21). No significant difference was found between groups in terms of bleeding and complication rates during the perioperative period. Mean follow-up duration was 26.48 ± 25.71 (range, 2-102) months. In this study, no clear supplementary benefit was observed in terms of safety and efficacy with the adjunction of coils to distal particle embolization in the management of AMLs.


  • Comparison of the Histological Response to Different Bulking Materials Used in Endoscopic Vesicoureteral Reflux Surgery

    by Ali Cansu Bozacı, Fazıl Tuncay Aki, Dilara Zeybek, Sevda Müftüoğlu, Serdar Tekgül

  • Global Perspective on Kidney Transplantation: Turkey

    by Oya Andacoglu, Fazil Tuncay Aki

    This is an Early Access article. Please select the PDF button, above, to view it.


  • Open Access

    Nefroloji Kitabı

    by Orçun Altunören, Garip Bekfilavioğlu, Ceren Önal, Bülent Altun, Tekin Akpolat, Ebru Ok, Çiğdem Mengüş, Ahmet Yalçın, Kenan Turgutalp, Caner Özer, et al.

    Renal Anatomi Orçun ALTUNÖREN Garip BEKFİLAVİOĞLU Renal Fizyoloji Ceren ÖNAL Bülent ALTUN Öykü ve Fizik İnceleme Tekin AKPOLAT Klirens Kavramı ve Glomerüler Filtrasyon Hızı Ölçüm Metotları Ebru SEVİNÇ OK İdrar Analizi ve Yorumlanması Çiğdem MENGÜŞ Ahmet Uğur YALÇIN Renal Görüntüleme Kenan TURGUTALP Caner ÖZER Renal Biyopsi ve Temel Patolojik İncelemeler Gökhan TEMİZ İlter BOZACI İdrar Miktarı Değişiklikleri (Poliüri, Oligüri, Anüri) Aydın ÜNAL İşeme Bozuklukları (Noktüri-Pollaküri-Dizüri-İdrar İnkontinansı) Murat Hayri SİPAHİOĞLU Sümeyra KOYUNCU Hematüriye Yaklaşım Cenk GÖKALP Soner DUMAN Proteinüriye Yaklaşım Serkan AKTÜRK Fatih DEDE Hücre Dışı Sıvı Volümü Düzenlenmesi ve Bozuklukları Seyhun KÜRŞAT Su ve Sodyum Metabolizması Bozuklukları Tevfik ECDER Potasyum Metabolizması ve Bozuklukları Bülent TOKGÖZ Cihan UYSAL Kalsiyum Metabolizması ve Bozuklukları Engin ONAN Özkan GÜNGÖR Fosfor Metabolizması ve Bozuklukları Aysel GÜRKAN TOÇOĞLU Savaş SİPAHİ Magnezyum Metabolizması ve Bozuklukları Eyüp KÜLAH Asit-Baz Dengesi Zeki AYDIN Metabolik Asidoz Özant HELVACI Galip GÜZ Metabolik Alkaloz Aykut SİFİL Solunumsal Asit-Baz Bozuklukları Halil AYDAR Garip ŞAHİN Karma Asit-Baz Bozuklukları Meltem SEZİŞ DEMİRCİ Gökhan ATAY Glomerüler Hastalıkların Patogenezi ve Sınıflaması Serhan TUĞLULAR Primer Glomerüler Hastalıkların Epidemiyolojisi Egemen CEBECİ Nefritik Sendrom İzzet Hakkı ARIKAN Nefrotik Sendrom Ferruh ARTUNÇ Minimal Değişim Hastalığı Meltem GÜRSU Membranöz Nefropati Savaş ÖZTÜRK İmmünglobülin A Nefropatisi Zerrin BİCİK BAHÇEBAŞI Fokal Segmental Glomerüloskleroz Abdülmecit YILDIZ Membranoproliferatif Glomerülonefrit ve C3 Glomerülopatisi Ahmet Burak DİRİM Yaşar ÇALIŞKAN Hızlı İlerleyen Glomerülonefritler Hayriye SAYARLIOĞLU Enfeksiyon İlişkili Glomerülonefritler Beyza ALGÜL DURAK Emre TUTAL İnce Bazal Membran Hastalığı Kamil DİLEK Diğer Glomerülonefritler Necmi EREN Serkan BAKIRDÖĞEN Lupus Nefriti Mustafa GÜLLÜLÜ Diğer Bağ Dokusu Hastalıkları ve Böbrek Didem TURGUT Diabetes Mellitus Epidemiyolojisi, Tanısı, Patogenezi, Kliniği ve Tedavisi Kültigin TÜRKMEN İsmail BALOĞLU Diyabetik Böbrek Hastalığı Neriman Sıla KOÇ Mustafa ARICI Gebelikte Böbrek Fizyolojisi Kübra KAYNAR Gebelikte Böbrek İlişkili Sorunlar Dilek TORUN Böbrek Hastalıklarında Gebelik Saime PAYDAŞ Üriner Sistem Enfeksiyonlarına Yaklaşım Faruk Hilmi TURGUT Kan Basıncı Kontrolü ve Hipertansiyon Fizyopatolojisi Ercan TÜRKMEN Nurol ARIK Primer Hipertansiyon ve Tedavisi Şükrü ULUSOY Gülsüm ÖZKAN Renovasküler Hipertansiyon Hadim AKOĞLU Endokrin Hipertansiyon Ayşa HACIOĞLU Züleyha KARACA Diğer Sekonder Hipertansiyon Nedenleri Ali Rıza UÇAR Halil YAZICI Hipertansif Aciller Kürşad ÖNEÇ Ülver BOZTEPE DERİCİ Ozmotik Diüretikler Özgür Akın OTO Tiazid ve Benzeri Diüretikler Ayça İNCİ Loop Diüretikleri Fatma AYERDEN EBİNÇ Diğer Diüretikler Yasemin COŞKUN YAVUZ Akuaretikler İrem PEMBEGÜL Kistik Böbrek Hastalıkları İsmail KOÇYİĞİT Eray EROĞLU Kalıtsal Tübüler Hastalıklar Ramazan ÇETİNKAYA Fabry Hastalığı Nurhan SEYAHİ Şeyda GÜL ÖZCAN Alport Hastalığı Ali Kemal KADİROĞLU Akut İnterstisyel Nefrit Ali GÜREL Ayhan DOĞUKAN Kronik İnterstisyel Nefrit Hakan AKDAM FMF ve Amiloidoz Harun AKAR Paraproteinemiler ve Miyelom Böbreği Vecihi BATUMAN Ürolojik Testler ve Değerlendirilmesi Aydın GÜÇLÜ Vezikoüreteral Reflü Funda SAĞLAM Böbrek Taş Hastalıkları Neslihan TEZCAN Rüya MUTLUAY Üriner Sistem Obstrüksiyonu Funda SARI Akut Böbrek Hasarının Tanımı ve Epidemiyolojisi Belda DURSUN Akut Böbrek Hasarında Klinik ve Komplikasyonlar Yelda GÜN Yavuz YENİÇERİOĞLU Akut Böbrek Hasarı Tedavisi Abdülmecit YILDIZ Alp İKİZLER Ezilme (Crush) Sendromu Mehmet Şükrü SEVER Trombotik Mikroanjiyopatiler Tuncay ŞAHUTOĞLU Ekrem KARA Yoğun Bakım Ünitesinde Akut Böbrek Hasarı ve Hemodinamik Destek Özlem USALAN Orhan ÖZDEMİR Yoğun Bakım Ünitesinde Renal Replasman Tedavileri Cuma Bülent GÜL Hepatitler ve Böbrek Alper AZAK Hepatorenal Sendrom Sinan KAZAN Sena ULU Kardiyorenal Sendrom: Patogenez ve Tanı Bülent HÜDDAM Kardiyorenal Sendrom: Tedavi İlter BOZACI Erhan TATAR Ürik Asitin Sistemik Hastalıklar ve Hipertansiyon Gelişimindeki Rolü Sidar ÇOPUR Mehmet KANBAY Gut ve Ürik Asit Nefropatisi Ender HÜR Aysun TORAMAN Kronik Böbrek Hastalığının Epidemiyolojisi ve Fizyopatolojisi...


  • Open Access

    Underlying Causes and Risk Factors of Chronic Renal Allograft Dysfunction Among Renal Transplant Recipients

    by Göksel Güven, Şeref Rahmi Yılmaz, Tolga Yıldırım, Fazıl Tuncay Akı, Yunus Erdem

    Objective: Dialysis or renal transplantation are the two treatment options for end-stage renal disease patients. Renal transplantation from an appropriate donor increases survival and quality of life compared to treatment with dialysis. Recent advances in immunosuppressive therapy have significantly improved the success in 1-year graft survival. However, the long-term graft survival remains the same. Therefore, we aimed to determine the underlying causes and risk factors of chronic allograft dysfunction in renal transplant recipients. Materials and Methods: From 2000 to 2012, all consecutive renal transplant recipients followed in our tertiary referral center who underwent renal biopsy due to an increase in serum creatinine level were enrolled. Etiologies of chronic allograft dysfunction were assessed according to pathologic results of renal biopsy specimens and laboratory findings. The immunological and non-immunological risk factors of chronic allograft dysfunction were screened and recorded retrospectively. Results: Eighty (80) renal transplant recipients with a mean age of 38±10 years were included in the study. Delayed graft function (p=0.007), history of acute rejection (p<0.001), positive panel reactive antibody (p=0.033) (Class I (p=0.013), Class II (p=0.006)), positive donor specific antibodies (p=0.001), number of recurrent acute rejections (p<0.001), number of human leukocyte antigens mismatches (p=0.051), cold ischemia time (p=0.001) were found to be risk factors for chronic allograft dysfunction. The donor specific antibodies positivity (p<0.001) and the panel reactive antibody positivity (Class I (p=0.003), Class II (p=0.001)) were significantly higher in patients with antibody mediated rejection than patients without antibody mediated rejection (p=0.002). Conclusion: Delayed graft function, presence and the number of acute rejections, increased cold ischemia time, panel reactive antibody positivity, donor specific antibodies positivity, and the number of human leukocyte antigens mismatches were risk factors for chronic allograft dysfunction.